You can look at the momentum for some stocks and have a feeling that it's about to end. Others, though, have such strong ...
A Bucks County woman is speaking out after her insurance company decided to no longer cover weight loss drugs.
In the ongoing quest to expand semaglutide’s clinical pedigree and cement the GLP-1's market position, Novo Nordisk is ...
Nicole Albanese, PharmD, discusses the science behind weight-loss drugs, their potential to treat other addictions as well as ...
In a recent episode of the global health and wellness show Bloom, host Gayle Guyardo welcomed Dr. Bharti Shetye, MD, MFOMA, a ...
The stupendous success of Mounjaro and Zepbound has made Lilly the largest drugmaker with a market cap of more than $734 billion. Lilly’s stock has gone up by 479% in the past five years ...
Metabolic medicines dominated life sciences headlines in 2024, a trend expected to continue into the new year. Other things ...
Dignity Health January marks Healthy Weight Awareness Month, and with the new year, many are setting health and weight loss ...
In the company's third-quarter report in October, Lilly reported sales of both Mounjaro and Zepbound that missed ... our mission of empowering investor success. We provide a platform for our ...